title: Different lengths of treatment with co-trimoxazole for acute uncomplicated urinary tract infections in women.
abstract: OBJECTIVE
  To compare three days' and seven days' treatment with co-trimoxazole in women with acute dysuria, strangury, and urinary frequency or urgency.
  
  
  METHODS
  Randomised double blind placebo controlled trial.
  
  
  METHODS
  General practices in the south east of The Netherlands.
  
  
  METHODS
  327 Non-pregnant female patients aged 12 to 65.
  
  
  METHODS
  161 Women were allocated to three days' treatment (co-trimoxazole 960 mg twice a day), and 166 women were allocated to seven days' treatment (co-trimoxazole 960 mg twice a day).
  
  
  METHODS
  Resolution of symptoms at one, two, and six weeks.
  
  
  RESULTS
  The rates for resolution of symptoms were not significantly different between the two groups. Cumulative rates of recurrence after three days' and seven days' treatment were 31/139 (22%) and 23/151 (15%) respectively six weeks after entry (p = 0.16). Adverse effects occurred in a quarter of women given three days' treatment compared with a third of women receiving seven days' treatment (p = 0.29). In only two patients did adverse effects necessitate stopping treatment.
  
  
  CONCLUSIONS
  Three days of co-trimoxazole seems to be as effective as a seven days' course for treating acute urinary tract infection in non-pregnant women.
authors.affiliation: Department of Medical Microbiology, University of Limburg, Maastricht, The Netherlands.
authors.forename: T A
authors.initials: TA
authors.lastname: Trienekens
authors.forename: E E
authors.initials: EE
authors.lastname: Stobberingh
authors.forename: R A
authors.initials: RA
authors.lastname: Winkens
authors.forename: A W
authors.initials: AW
authors.lastname: Houben
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000892:Anti-Infective Agents, Urinary / Q000008:administration & dosage* / Q000627:therapeutic use; D002648:Child; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008875:Middle Aged; D016032:Randomized Controlled Trials as Topic; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000008:administration & dosage* / Q000627:therapeutic use; D014552:Urinary Tract Infections / Q000188:drug therapy*
chemical_list: D000892:Anti-Infective Agents, Urinary; D015662:Trimethoprim, Sulfamethoxazole Drug Combination